Aerosol Masks Market - Forecast(2024 - 2030)

Aerosol Masks Market Overview:

Aerosol Masks Market size is estimated to reach $63.7 billion by 2030, growing at a CAGR of 7.3% during the forecast period 2024-2030. Increased demand for personalized masks, growing demand for home healthcare, increasing prevalence of respiratory diseases and development of new delivery technologies that can improve the efficiency and safety of aerosol therapy are propelling the Aerosol Masks Market growth.

Additionally, the increasing prevalence of respiratory diseases, such as asthma, cystic fibrosis and chronic obstructive pulmonary diseases are creating substantial growth opportunities for the Aerosol Masks Market. WHO predicts that chronic obstructive pulmonary diseases (COPD) will become the third leading cause of death worldwide by 2030. Simultaneously, growing popularity of personalized masks and rising demand for home healthcare are some of the major Aerosol Masks Market opportunities. These factors positively influence the Aerosol Masks Market outlook during the forecast period.

Market Snapshot:

Aerosol Masks Market - Report Coverage:

The “Aerosol Masks Market Report - Forecast (2024-2030)” by IndustryARC, covers an in-depth analysis of the following segments in the Aerosol Masks Market.

COVID-19 / Ukraine Crisis - Impact Analysis: 

●    The demand for aerosol masks has increased significantly due to the respiratory complications associated with COVID-19, particularly among patients with severe illness who require respiratory support. The virus is primarily spread through respiratory droplets, and healthcare providers have been using aerosol masks and other respiratory devices to treat COVID-19 patients. Aerosol masks are also used in the administration of oxygen therapy, which is a common treatment for patients with COVID-19.

●   Ukraine is a one of the key producer of medical devices, including aerosol masks in the region. With the ongoing conflict between Ukraine and Russia, the production and supply of these devices are expected to get disrupted. Moreover, the war is expected to increase the demand for aerosol masks in both Ukraine and Russia due to the respiratory complications associated with military conflict and exposure to toxic chemicals. Lastly, the trade restrictions, currency fluctuations and political instability could all have a negative impact on the market.

Key Takeaways:

●      Asia-Pacific to Witness Fastest Market Growth

     Geographically, in the global Aerosol Masks market, Asia-Pacific is analyzed to grow with the highest CAGR of 8% during the forecast period 2024-2030. Air pollution remains a major problem in various parts of Asia-pacific, and people are becoming more aware of the health risks associated with exposure to harmful particles in the air. While that is one major factor driving the demand for aerosol masks in this region. On 19 December 2022, WHO reported that combined effects of ambient air pollution and household air pollution are associated with 6.7 million premature deaths annually and 89% of those deaths occurred in low and middle-income countries and the greatest number in the South-East Asia region during the forecast period.

●      Standard Aerosol Masks Segment Would Continue Its Dominance

In the Aerosol Masks Market analysis, the standard aerosol masks segment is estimated to grow with the highest CAGR of 7.9% during the forecast period 2024-2030. When compared with elongated aerosol masks, the standard ones are less expensive, more comfortable and more widely available. Due to the growth in the number of patients who require the administration of nebulized solution, an increase in the usage of conventional aerosol masks for oxygen therapy, and a rise in the prevalence of chronic respiratory illnesses, the standard aerosol masks segment continues to dominate the market.

●      Hospitals and Clinics are the Largest End-users

According to the Aerosol Masks Market forecast, the hospitals and clinics segment held the largest market share of 41.1% in 2023. Hospitals and clinics treat a large number of patients with respiratory conditions such as asthma, chronic obstructive pulmonary disease (COPD), pneumonia, and bronchitis. Aerosol masks are medical devices used to administer bronchodilators, deliver aerosolized medications and antibiotics directly to the respiratory tract for patients with respiratory conditions. On World Lung Day, 25 September 2022, the Forum of International Respiratory Societies (FIRS), of which GOLD is a founding member Global Impact of Respiratory Disease report shows asthma is one of the commonest non-communicable diseases globally affecting 262 million people and COPD affecting 200 million people.

●      Increasing Levels of Air Pollution

The increasing air pollution levels are steadily fueling the growth of the aerosol masks market during the forecast period. In many parts of the world, especially in Asia-Pacific, air pollution is a major risk factor for respiratory diseases. In November 2022, University of Oxford reported, Air pollutants kill around seven million people every year. Much of this pollution is tiny particles suspended in the air which, when inhaled, can cause people to develop heart and lung diseases, as well as cancer.

●      Infection Control and Cross-Contamination is a challenge

Ensuring proper infection control measures and preventing cross-contamination in healthcare settings is crucial. Aerosol masks, being reusable medical devices, need thorough cleaning and disinfection after each use, which can be time-consuming and labor-intensive. Failure to maintain proper hygiene protocols can lead to the transmission of infections between patients, is a major challenge for market growth.

Key Market Players:

Product/Service launches, approvals, patents and events, acquisitions, partnerships and collaborations are key strategies adopted by players in the Aerosol Masks Market. The top 10 companies in this industry are listed below:

1. 3M Company (Aura, Versaflo)
2. Medline Industries, Inc. (SideStream, SunMed)
3. Teleflex Incorporated (Allegiance, CareFusion)
4. Smiths Medical, Inc. (Portex, AMBU)
5. Vyaire Medical, Inc. (AirLife, Aeroneb)
6. Becton, Dickinson and Company (PowerGlide, StatLock)
7. ResMed Inc. (AirFt, AirTouch)
8. Mercury Medical (OxyMask, OxyKid)
9. Armstrong Medical Industries, Inc. (Brand name not found)
10. Intersurgical Ltd. (EcoLite, Cirrus)

Scope of Report: